Dr. Jeannette Doorduijn
Claim this profileErasmus Medisch Centrum
Studies B-Cell Lymphoma
Studies Lymphoma
1 reported clinical trial
1 drug studied
More about Jeannette Doorduijn
Clinical Trial Related4 years of experience running clinical trials · Led 1 trial as a Principal Investigator · 0 Active Clinical TrialsTreatments Jeannette Doorduijn has experience with
- LOXO-305
Breakdown of trials Jeannette Doorduijn has run
B-Cell Lymphoma
Childhood Blood Disease
Mantle Cell Lymphoma
Mixed-Cell Lymphoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Jeannette Doorduijn specialize in?
Jeannette Doorduijn focuses on B-Cell Lymphoma and Lymphoma. In particular, much of their work with B-Cell Lymphoma has involved treating patients, or patients who are undergoing treatment.
Is Jeannette Doorduijn currently recruiting for clinical trials?
No, Jeannette Doorduijn is not currently recruiting for any clinical trials. This may change in the future, so check back later.
Are there any treatments that Jeannette Doorduijn has studied deeply?
Yes, Jeannette Doorduijn has studied treatments such as LOXO-305.
What is the best way to schedule an appointment with Jeannette Doorduijn?
Apply for one of the trials that Jeannette Doorduijn is conducting.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.